Concepts (220)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Uganda | 42 | 2024 | 1239 | 2.650 |
Why?
|
HIV Infections | 32 | 2024 | 16678 | 1.520 |
Why?
|
Carotid Artery Diseases | 5 | 2021 | 882 | 1.210 |
Why?
|
Rural Population | 11 | 2020 | 2207 | 0.870 |
Why?
|
HIV Seronegativity | 3 | 2021 | 211 | 0.840 |
Why?
|
Anti-HIV Agents | 7 | 2021 | 4250 | 0.810 |
Why?
|
Dyspepsia | 1 | 2022 | 114 | 0.810 |
Why?
|
Hypertension | 8 | 2022 | 8455 | 0.750 |
Why?
|
Esophageal Neoplasms | 3 | 2022 | 1581 | 0.720 |
Why?
|
Fatty Acid-Binding Proteins | 2 | 2019 | 301 | 0.710 |
Why?
|
Helicobacter pylori | 1 | 2022 | 381 | 0.690 |
Why?
|
Helicobacter Infections | 1 | 2022 | 385 | 0.690 |
Why?
|
HIV Long-Term Survivors | 1 | 2020 | 126 | 0.690 |
Why?
|
Biomass | 1 | 2019 | 125 | 0.670 |
Why?
|
Heating | 1 | 2019 | 97 | 0.660 |
Why?
|
Urban Health | 1 | 2021 | 547 | 0.650 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 2 | 2018 | 293 | 0.620 |
Why?
|
Cooking | 1 | 2019 | 312 | 0.580 |
Why?
|
Anti-Retroviral Agents | 5 | 2019 | 1712 | 0.570 |
Why?
|
HIV Seropositivity | 1 | 2021 | 970 | 0.540 |
Why?
|
Preventive Health Services | 1 | 2020 | 575 | 0.500 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2016 | 425 | 0.490 |
Why?
|
Decision Support Techniques | 3 | 2018 | 1952 | 0.470 |
Why?
|
Interleukin-6 | 3 | 2019 | 3199 | 0.430 |
Why?
|
Cardiology Service, Hospital | 1 | 2014 | 246 | 0.420 |
Why?
|
Air Pollution, Indoor | 1 | 2019 | 855 | 0.420 |
Why?
|
Education, Medical, Continuing | 1 | 2017 | 839 | 0.410 |
Why?
|
C-Reactive Protein | 3 | 2019 | 3766 | 0.380 |
Why?
|
Heart Failure | 4 | 2022 | 10856 | 0.380 |
Why?
|
Deglutition Disorders | 1 | 2016 | 604 | 0.370 |
Why?
|
Risk Factors | 21 | 2022 | 72145 | 0.360 |
Why?
|
Plaque, Atherosclerotic | 1 | 2021 | 1499 | 0.360 |
Why?
|
Antihypertensive Agents | 2 | 2016 | 2043 | 0.360 |
Why?
|
Receptors, Cell Surface | 2 | 2018 | 2867 | 0.350 |
Why?
|
Antigens, CD | 3 | 2018 | 4024 | 0.340 |
Why?
|
Hospitalization | 4 | 2018 | 10232 | 0.330 |
Why?
|
Delivery of Health Care, Integrated | 3 | 2020 | 941 | 0.300 |
Why?
|
Blood Pressure | 3 | 2019 | 8541 | 0.280 |
Why?
|
Lower Extremity | 1 | 2014 | 1151 | 0.280 |
Why?
|
Self Report | 2 | 2019 | 3548 | 0.280 |
Why?
|
Cross-Sectional Studies | 13 | 2023 | 24913 | 0.280 |
Why?
|
Case-Control Studies | 7 | 2021 | 21719 | 0.280 |
Why?
|
Prevalence | 11 | 2022 | 15194 | 0.260 |
Why?
|
Diabetes Mellitus | 4 | 2022 | 5724 | 0.260 |
Why?
|
Feces | 2 | 2022 | 1394 | 0.250 |
Why?
|
Echocardiography | 1 | 2017 | 5097 | 0.250 |
Why?
|
Medication Adherence | 1 | 2016 | 2055 | 0.250 |
Why?
|
Blood Pressure Determination | 2 | 2019 | 632 | 0.250 |
Why?
|
Adult | 28 | 2022 | 213712 | 0.240 |
Why?
|
Kenya | 3 | 2021 | 685 | 0.230 |
Why?
|
Middle Aged | 29 | 2023 | 213127 | 0.230 |
Why?
|
Male | 37 | 2024 | 349538 | 0.230 |
Why?
|
Alcohol Drinking | 1 | 2016 | 3957 | 0.230 |
Why?
|
Peripheral Arterial Disease | 1 | 2014 | 1184 | 0.230 |
Why?
|
Quality of Life | 4 | 2024 | 12730 | 0.220 |
Why?
|
Female | 38 | 2023 | 379592 | 0.220 |
Why?
|
Inflammation | 2 | 2019 | 10578 | 0.220 |
Why?
|
Humans | 53 | 2024 | 742088 | 0.210 |
Why?
|
Africa South of the Sahara | 3 | 2020 | 724 | 0.210 |
Why?
|
Clinical Competence | 1 | 2017 | 4681 | 0.200 |
Why?
|
Loneliness | 1 | 2024 | 184 | 0.200 |
Why?
|
Lung Diseases, Obstructive | 1 | 2022 | 316 | 0.190 |
Why?
|
Africa, Western | 1 | 2020 | 154 | 0.190 |
Why?
|
Antiretroviral Therapy, Highly Active | 3 | 2019 | 1872 | 0.190 |
Why?
|
Cardiovascular Diseases | 4 | 2022 | 15108 | 0.190 |
Why?
|
Smoking | 2 | 2022 | 8969 | 0.190 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2016 | 4029 | 0.190 |
Why?
|
Rural Health | 2 | 2019 | 305 | 0.190 |
Why?
|
Risk Assessment | 6 | 2021 | 23320 | 0.190 |
Why?
|
Eclampsia | 1 | 2020 | 58 | 0.180 |
Why?
|
Communicable Disease Control | 2 | 2023 | 854 | 0.180 |
Why?
|
HIV Seroprevalence | 1 | 2019 | 86 | 0.170 |
Why?
|
Charcoal | 1 | 2019 | 63 | 0.170 |
Why?
|
Coal | 1 | 2019 | 118 | 0.170 |
Why?
|
Wood | 1 | 2019 | 88 | 0.170 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2022 | 947 | 0.170 |
Why?
|
Predictive Value of Tests | 3 | 2021 | 15056 | 0.160 |
Why?
|
Maternal Mortality | 1 | 2020 | 310 | 0.150 |
Why?
|
Cohort Studies | 12 | 2022 | 40450 | 0.150 |
Why?
|
Nigeria | 1 | 2020 | 731 | 0.150 |
Why?
|
Stillbirth | 1 | 2020 | 346 | 0.150 |
Why?
|
Longitudinal Studies | 4 | 2022 | 13921 | 0.150 |
Why?
|
Fasting | 2 | 2020 | 1589 | 0.150 |
Why?
|
Antigens, Bacterial | 1 | 2022 | 1170 | 0.140 |
Why?
|
Glasgow Coma Scale | 1 | 2018 | 570 | 0.140 |
Why?
|
Aged | 16 | 2024 | 162944 | 0.140 |
Why?
|
Carbon Monoxide | 1 | 2019 | 531 | 0.140 |
Why?
|
Tanzania | 1 | 2020 | 1344 | 0.140 |
Why?
|
Developing Countries | 2 | 2019 | 2789 | 0.140 |
Why?
|
Acute Disease | 2 | 2018 | 7141 | 0.130 |
Why?
|
Prognosis | 4 | 2020 | 29010 | 0.130 |
Why?
|
Hypertension, Pregnancy-Induced | 1 | 2020 | 485 | 0.130 |
Why?
|
Body Mass Index | 4 | 2022 | 12695 | 0.120 |
Why?
|
Prospective Studies | 5 | 2021 | 53187 | 0.120 |
Why?
|
Viral Load | 2 | 2020 | 3292 | 0.120 |
Why?
|
Respiratory Tract Diseases | 1 | 2019 | 722 | 0.120 |
Why?
|
Ankle Brachial Index | 1 | 2014 | 154 | 0.120 |
Why?
|
Hematoma | 1 | 2018 | 755 | 0.120 |
Why?
|
Patient Dropouts | 1 | 2016 | 421 | 0.110 |
Why?
|
Gastroenterology | 1 | 2019 | 534 | 0.110 |
Why?
|
Life Expectancy | 1 | 2020 | 1183 | 0.110 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2018 | 609 | 0.110 |
Why?
|
Atherosclerosis | 2 | 2022 | 3428 | 0.110 |
Why?
|
International Cooperation | 1 | 2019 | 1421 | 0.110 |
Why?
|
Registries | 2 | 2018 | 8077 | 0.110 |
Why?
|
Spirometry | 3 | 2022 | 862 | 0.110 |
Why?
|
Aftercare | 1 | 2018 | 860 | 0.100 |
Why?
|
Needs Assessment | 1 | 2018 | 1146 | 0.100 |
Why?
|
Forced Expiratory Volume | 3 | 2022 | 1741 | 0.100 |
Why?
|
Reproducibility of Results | 3 | 2022 | 19862 | 0.100 |
Why?
|
Lung | 2 | 2022 | 9826 | 0.100 |
Why?
|
Carotid Arteries | 3 | 2022 | 952 | 0.100 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2022 | 2059 | 0.100 |
Why?
|
Pre-Eclampsia | 1 | 2020 | 1196 | 0.100 |
Why?
|
Tuberculosis, Pulmonary | 1 | 2017 | 810 | 0.100 |
Why?
|
Health Resources | 1 | 2017 | 911 | 0.100 |
Why?
|
Health Facilities | 1 | 2016 | 573 | 0.100 |
Why?
|
Statistics as Topic | 1 | 2017 | 2372 | 0.100 |
Why?
|
Cholesterol, LDL | 1 | 2020 | 2354 | 0.090 |
Why?
|
Incidence | 3 | 2020 | 20928 | 0.090 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2016 | 859 | 0.090 |
Why?
|
Sensitivity and Specificity | 2 | 2022 | 14720 | 0.090 |
Why?
|
Academic Medical Centers | 1 | 2019 | 2749 | 0.080 |
Why?
|
Qualitative Research | 3 | 2022 | 2680 | 0.080 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2018 | 4379 | 0.080 |
Why?
|
Time Factors | 2 | 2021 | 40054 | 0.080 |
Why?
|
Health Status Disparities | 1 | 2020 | 1794 | 0.080 |
Why?
|
Health Policy | 1 | 2020 | 2657 | 0.080 |
Why?
|
Mass Screening | 2 | 2020 | 5238 | 0.080 |
Why?
|
Cause of Death | 1 | 2018 | 3571 | 0.080 |
Why?
|
Health Personnel | 1 | 2021 | 3210 | 0.070 |
Why?
|
Cerebral Hemorrhage | 1 | 2018 | 2643 | 0.070 |
Why?
|
Life Style | 1 | 2018 | 3824 | 0.070 |
Why?
|
Pandemics | 2 | 2023 | 8328 | 0.070 |
Why?
|
Body Weight | 1 | 2017 | 4664 | 0.070 |
Why?
|
Health Status | 1 | 2020 | 4030 | 0.070 |
Why?
|
Heart Diseases | 1 | 2019 | 2789 | 0.070 |
Why?
|
Smoking Cessation | 1 | 2018 | 2068 | 0.070 |
Why?
|
Respiratory Function Tests | 2 | 2022 | 1613 | 0.070 |
Why?
|
Insulin Resistance | 1 | 2019 | 3861 | 0.070 |
Why?
|
Environmental Exposure | 1 | 2019 | 4231 | 0.060 |
Why?
|
Socioeconomic Factors | 1 | 2018 | 7770 | 0.060 |
Why?
|
Multivariate Analysis | 2 | 2018 | 12242 | 0.060 |
Why?
|
Healthcare Disparities | 1 | 2020 | 3151 | 0.060 |
Why?
|
Disease Progression | 1 | 2021 | 13256 | 0.060 |
Why?
|
Primary Health Care | 1 | 2021 | 4551 | 0.060 |
Why?
|
Blood Glucose | 1 | 2019 | 6249 | 0.060 |
Why?
|
Odds Ratio | 1 | 2016 | 9846 | 0.060 |
Why?
|
Hospital Mortality | 2 | 2014 | 5310 | 0.060 |
Why?
|
Sexual Behavior | 2 | 2024 | 2050 | 0.060 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2017 | 3038 | 0.060 |
Why?
|
Lipids | 1 | 2014 | 3302 | 0.050 |
Why?
|
CD4 Lymphocyte Count | 2 | 2018 | 2557 | 0.050 |
Why?
|
HIV-1 | 1 | 2019 | 6934 | 0.050 |
Why?
|
Genome-Wide Association Study | 1 | 2020 | 12220 | 0.050 |
Why?
|
Severity of Illness Index | 2 | 2019 | 15530 | 0.050 |
Why?
|
Sex Factors | 3 | 2019 | 10392 | 0.050 |
Why?
|
Coronary Artery Disease | 1 | 2020 | 6454 | 0.050 |
Why?
|
Vital Capacity | 1 | 2022 | 922 | 0.040 |
Why?
|
Sepsis | 1 | 2014 | 2589 | 0.040 |
Why?
|
Diastole | 1 | 2022 | 791 | 0.040 |
Why?
|
Stroke | 1 | 2022 | 9963 | 0.040 |
Why?
|
Physicians | 1 | 2017 | 4554 | 0.040 |
Why?
|
Logistic Models | 1 | 2014 | 13403 | 0.040 |
Why?
|
Public-Private Sector Partnerships | 1 | 2019 | 120 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2019 | 11695 | 0.040 |
Why?
|
Community-Institutional Relations | 1 | 2019 | 204 | 0.040 |
Why?
|
CpG Islands | 1 | 2022 | 1170 | 0.040 |
Why?
|
Limit of Detection | 1 | 2018 | 264 | 0.040 |
Why?
|
Poisson Distribution | 1 | 2018 | 512 | 0.040 |
Why?
|
Gene Expression Regulation | 1 | 2015 | 12071 | 0.040 |
Why?
|
South Africa | 1 | 2022 | 1728 | 0.040 |
Why?
|
Homosexuality, Male | 1 | 2024 | 1238 | 0.030 |
Why?
|
Adolescent | 2 | 2022 | 85649 | 0.030 |
Why?
|
Lost to Follow-Up | 1 | 2016 | 105 | 0.030 |
Why?
|
Macrophage Activation | 1 | 2018 | 558 | 0.030 |
Why?
|
HIV | 1 | 2023 | 1600 | 0.030 |
Why?
|
Glucose Intolerance | 1 | 2019 | 577 | 0.030 |
Why?
|
Biostatistics | 1 | 2016 | 160 | 0.030 |
Why?
|
Public Sector | 1 | 2016 | 264 | 0.030 |
Why?
|
Sex Distribution | 1 | 2019 | 2295 | 0.030 |
Why?
|
Quality-Adjusted Life Years | 1 | 2020 | 1679 | 0.030 |
Why?
|
Comorbidity | 2 | 2018 | 10372 | 0.030 |
Why?
|
Cholesterol, HDL | 1 | 2020 | 1813 | 0.030 |
Why?
|
Gene Frequency | 1 | 2020 | 3587 | 0.030 |
Why?
|
Activities of Daily Living | 1 | 2022 | 2414 | 0.030 |
Why?
|
Bacteria | 1 | 2024 | 2102 | 0.030 |
Why?
|
Program Development | 1 | 2019 | 1314 | 0.030 |
Why?
|
Respiratory Rate | 1 | 2014 | 162 | 0.030 |
Why?
|
Proportional Hazards Models | 2 | 2018 | 12344 | 0.030 |
Why?
|
Triglycerides | 1 | 2020 | 2450 | 0.030 |
Why?
|
Cooperative Behavior | 1 | 2019 | 1503 | 0.030 |
Why?
|
Gestational Age | 1 | 2020 | 3490 | 0.030 |
Why?
|
Program Evaluation | 1 | 2019 | 2485 | 0.020 |
Why?
|
Pregnancy Outcome | 1 | 2020 | 2795 | 0.020 |
Why?
|
Forecasting | 1 | 2019 | 2948 | 0.020 |
Why?
|
United States | 1 | 2017 | 69693 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2019 | 57683 | 0.020 |
Why?
|
Polymorphism, Genetic | 1 | 2020 | 4328 | 0.020 |
Why?
|
Regression Analysis | 1 | 2018 | 6452 | 0.020 |
Why?
|
Insurance, Health | 1 | 2021 | 2493 | 0.020 |
Why?
|
DNA Methylation | 1 | 2022 | 4282 | 0.020 |
Why?
|
DNA | 1 | 2022 | 7289 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2021 | 3527 | 0.020 |
Why?
|
Cost-Benefit Analysis | 1 | 2020 | 5385 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2019 | 3584 | 0.020 |
Why?
|
Ultrasonography | 1 | 2020 | 5978 | 0.020 |
Why?
|
Hospitals | 1 | 2021 | 3937 | 0.020 |
Why?
|
Survival Rate | 1 | 2020 | 12773 | 0.020 |
Why?
|
Electrocardiography | 1 | 2019 | 6440 | 0.020 |
Why?
|
Young Adult | 2 | 2022 | 56350 | 0.010 |
Why?
|
Health Services Accessibility | 1 | 2021 | 5133 | 0.010 |
Why?
|
Heart Rate | 1 | 2014 | 4091 | 0.010 |
Why?
|
Age Factors | 1 | 2018 | 18355 | 0.010 |
Why?
|
Cytokines | 1 | 2015 | 7317 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2020 | 25575 | 0.010 |
Why?
|
Depression | 1 | 2019 | 7733 | 0.010 |
Why?
|
Pregnancy | 1 | 2020 | 29087 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2018 | 20086 | 0.010 |
Why?
|
Child | 1 | 2022 | 77478 | 0.010 |
Why?
|
Concepts
(220)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(42)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_